ArticleGeographical analysis2021
Reproducible Science Is Vital for a Stronger Evidence Base During the COVID-19 Pandemic.
Article in Geographical analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Reproducible research becomes even more imperative as we build the evidence base on SARS-CoV-2 epidemiology, diagnosis, prevention, and treatment. In his study, Paez assessed the reproducibility of COVID-19 research during the pandemic, using a case study of population density. He found that most articles that assess the relationship of population density and COVID-19 outcomes do not publicly share data and code, except for a few, including our paper, which he stated "illustrates the importance of good reproducibility practices". Paez recreated our analysis using our code and data from the perspective of spatial analysis, and his new model came to a different conclusion. The disparity between our and Paez's findings, as well as other existing literature on the topic, give greater impetus to the need for further research. As there has been near exponential growth of COVID-19 research across a wide range of scientific disciplines, reproducible science is a vital component to produce reliable, rigorous, and robust evidence on COVID-19, which will be essential to inform clinical practice and policy in order to effectively eliminate the pandemic.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.